chr19-17825546-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_000215.4(JAK3):​c.*1197G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00753 in 199,536 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0073 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0081 ( 1 hom. )

Consequence

JAK3
NM_000215.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.400

Publications

2 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-17825546-C-T is Benign according to our data. Variant chr19-17825546-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 328474.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00734 (1118/152262) while in subpopulation AMR AF = 0.0111 (170/15278). AF 95% confidence interval is 0.0103. There are 8 homozygotes in GnomAd4. There are 530 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAK3NM_000215.4 linkc.*1197G>A 3_prime_UTR_variant Exon 24 of 24 ENST00000458235.7 NP_000206.2 P52333-1A0A024R7M7
JAK3NM_001440439.1 linkc.*1197G>A 3_prime_UTR_variant Exon 24 of 24 NP_001427368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAK3ENST00000458235.7 linkc.*1197G>A 3_prime_UTR_variant Exon 24 of 24 5 NM_000215.4 ENSP00000391676.1 P52333-1
JAK3ENST00000696967.1 linkn.3749G>A non_coding_transcript_exon_variant Exon 19 of 19
JAK3ENST00000696968.1 linkn.1805G>A non_coding_transcript_exon_variant Exon 3 of 3
JAK3ENST00000527031.5 linkn.2279-236G>A intron_variant Intron 13 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.00735
AC:
1118
AN:
152144
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0111
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.00358
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0110
Gnomad OTH
AF:
0.00766
GnomAD4 exome
AF:
0.00812
AC:
384
AN:
47274
Hom.:
1
Cov.:
0
AF XY:
0.00876
AC XY:
192
AN XY:
21918
show subpopulations
African (AFR)
AF:
0.00158
AC:
3
AN:
1896
American (AMR)
AF:
0.00317
AC:
4
AN:
1262
Ashkenazi Jewish (ASJ)
AF:
0.00709
AC:
21
AN:
2962
East Asian (EAS)
AF:
0.00
AC:
0
AN:
7860
South Asian (SAS)
AF:
0.00503
AC:
2
AN:
398
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28
Middle Eastern (MID)
AF:
0.0211
AC:
6
AN:
284
European-Non Finnish (NFE)
AF:
0.0107
AC:
307
AN:
28622
Other (OTH)
AF:
0.0103
AC:
41
AN:
3962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00734
AC:
1118
AN:
152262
Hom.:
8
Cov.:
31
AF XY:
0.00712
AC XY:
530
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41556
American (AMR)
AF:
0.0111
AC:
170
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4828
European-Finnish (FIN)
AF:
0.00358
AC:
38
AN:
10608
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0110
AC:
748
AN:
68022
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00821
Hom.:
0
Bravo
AF:
0.00739
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.6
DANN
Benign
0.84
PhyloP100
0.40
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213415; hg19: chr19-17936355; API